[Hypoxic cell radiosensitizer present status and problems from viewpoint of clinical radiotherapy]. 1990

K Ono, and K Sasai, and S Masunaga, and Y Kitakabu, and M Fushiki, and Y Kinashi, and M Takahashi, and M Abe
Dept. of Radiology, Kyoto Univ. School of Med.

The results of clinical trials of hypoxic cell radiosensitizers were reviewed in order to clarify the present status and problems in this field. Most trials failed to show an effectiveness of the combination, however, some ENT tumors and bladder cancers were improved in local tumor responses and survivals. A selection of the patients suitable for the combination and development of simple method for the selection are indispensable. SERs necessary for clinical radiotherapy are considered to be larger than 1.2 at 2 Gy fraction level. Present hypoxic cell radiosensitizers have no significant effects on alpha values. Since radiation responses at low radiation dose ranges are dominated by alpha values, the chemicals having an effects on alpha values have to be developed.

UI MeSH Term Description Entries
D008920 Misonidazole A nitroimidazole that sensitizes normally radio-resistant hypoxic cells to radiation. It may also be directly cytotoxic to hypoxic cells and has been proposed as an antineoplastic. Ro 07-0582,Ro 7-0582,alpha-(Methoxymethyl)-2-nitro-1H-imidazole-1-ethanol,Ro 07 0582,Ro 070582,Ro 7 0582,Ro 70582
D010100 Oxygen An element with atomic symbol O, atomic number 8, and atomic weight [15.99903; 15.99977]. It is the most abundant element on earth and essential for respiration. Dioxygen,Oxygen-16,Oxygen 16
D010610 Pharyngeal Neoplasms Tumors or cancer of the PHARYNX. Cancer of Pharynx,Pharyngeal Cancer,Cancer of the Pharynx,Neoplasms, Pharyngeal,Neoplasms, Pharynx,Pharnyx Cancer,Pharynx Neoplasms,Cancer, Pharnyx,Cancer, Pharyngeal,Cancers, Pharnyx,Cancers, Pharyngeal,Neoplasm, Pharyngeal,Neoplasm, Pharynx,Pharnyx Cancers,Pharyngeal Cancers,Pharyngeal Neoplasm,Pharynx Cancer,Pharynx Cancers,Pharynx Neoplasm
D011838 Radiation-Sensitizing Agents Drugs used to potentiate the effectiveness of radiation therapy in destroying unwanted cells. Radiation Sensitizer,Radiosensitizing Agent,Radiosensitizing Agents,Agents, Radiation-Sensitizing,Radiation Sensitizers,Radiation Sensitizing Agents,Radiation-Sensitizing Drugs,Radiation-Sensitizing Effect,Radiation-Sensitizing Effects,Radiosensitizing Drugs,Radiosensitizing Effect,Radiosensitizing Effects,Agent, Radiosensitizing,Agents, Radiation Sensitizing,Agents, Radiosensitizing,Drugs, Radiation-Sensitizing,Drugs, Radiosensitizing,Effect, Radiation-Sensitizing,Effect, Radiosensitizing,Effects, Radiation-Sensitizing,Effects, Radiosensitizing,Radiation Sensitizing Drugs,Radiation Sensitizing Effect,Radiation Sensitizing Effects,Sensitizer, Radiation,Sensitizers, Radiation,Sensitizing Agents, Radiation
D011879 Radiotherapy Dosage The total amount of radiation absorbed by tissues as a result of radiotherapy. Dosage, Radiotherapy,Dosages, Radiotherapy,Radiotherapy Dosages
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014594 Uterine Neoplasms Tumors or cancer of the UTERUS. Cancer of Uterus,Uterine Cancer,Cancer of the Uterus,Neoplasms, Uterine,Neoplasms, Uterus,Uterus Cancer,Uterus Neoplasms,Cancer, Uterine,Cancer, Uterus,Cancers, Uterine,Cancers, Uterus,Neoplasm, Uterine,Neoplasm, Uterus,Uterine Cancers,Uterine Neoplasm,Uterus Cancers,Uterus Neoplasm
D015687 Cell Hypoxia A condition of decreased oxygen content at the cellular level. Anoxia, Cellular,Cell Anoxia,Hypoxia, Cellular,Anoxia, Cell,Anoxias, Cell,Anoxias, Cellular,Cell Anoxias,Cell Hypoxias,Cellular Anoxia,Cellular Anoxias,Cellular Hypoxia,Cellular Hypoxias,Hypoxia, Cell,Hypoxias, Cell,Hypoxias, Cellular

Related Publications

K Ono, and K Sasai, and S Masunaga, and Y Kitakabu, and M Fushiki, and Y Kinashi, and M Takahashi, and M Abe
October 1990, Gan no rinsho. Japan journal of cancer clinics,
K Ono, and K Sasai, and S Masunaga, and Y Kitakabu, and M Fushiki, and Y Kinashi, and M Takahashi, and M Abe
June 1989, Gan to kagaku ryoho. Cancer & chemotherapy,
K Ono, and K Sasai, and S Masunaga, and Y Kitakabu, and M Fushiki, and Y Kinashi, and M Takahashi, and M Abe
April 1989, Gan to kagaku ryoho. Cancer & chemotherapy,
K Ono, and K Sasai, and S Masunaga, and Y Kitakabu, and M Fushiki, and Y Kinashi, and M Takahashi, and M Abe
July 1983, Rinsho hoshasen. Clinical radiography,
K Ono, and K Sasai, and S Masunaga, and Y Kitakabu, and M Fushiki, and Y Kinashi, and M Takahashi, and M Abe
February 1983, Iyo denshi to seitai kogaku. Japanese journal of medical electronics and biological engineering,
K Ono, and K Sasai, and S Masunaga, and Y Kitakabu, and M Fushiki, and Y Kinashi, and M Takahashi, and M Abe
October 2010, International journal of radiation oncology, biology, physics,
K Ono, and K Sasai, and S Masunaga, and Y Kitakabu, and M Fushiki, and Y Kinashi, and M Takahashi, and M Abe
July 1986, [Hokkaido igaku zasshi] The Hokkaido journal of medical science,
K Ono, and K Sasai, and S Masunaga, and Y Kitakabu, and M Fushiki, and Y Kinashi, and M Takahashi, and M Abe
May 1964, Rassegna clinico-scientifica,
K Ono, and K Sasai, and S Masunaga, and Y Kitakabu, and M Fushiki, and Y Kinashi, and M Takahashi, and M Abe
June 1983, Rinsho hoshasen. Clinical radiography,
K Ono, and K Sasai, and S Masunaga, and Y Kitakabu, and M Fushiki, and Y Kinashi, and M Takahashi, and M Abe
October 1983, Gan no rinsho. Japan journal of cancer clinics,
Copied contents to your clipboard!